SELL and hematocrit: However, the levels of FSC-A on HLA DR+ T cell (OR = 0.935, 95% CI = 0.891–0.981, P = 0.006) and CD62L on monocyte (OR = 0.963, 95% CI = 0.937–0.990, P = 0.008) were associated with disease risk of HT, which suggests the protective role of FSC-A on HLA DR+ T cell and CD62L on monocyte in HT.